United Therapeutics Corporation drugs

6 results

  • adcirca

    (Tadalafil)
    United Therapeutics Corporation
    ADCIRCA® is indicated for treating pulmonary arterial hypertension (PAH) to improve exercise ability, specifically in patients with NYHA Functional Class II-III symptoms, including idiopathic, heritable PAH, and PAH associated with connective tissue diseases.
    Medication Details
    Drug Interactions

  • orenitram

    (treprostinil)
    United Therapeutics Corporation
    Orenitram is indicated for treating pulmonary arterial hypertension (PAH) to delay disease progression and improve exercise capacity, primarily in patients with WHO functional class II-III symptoms, including idiopathic, heritable, or connective tissue disease-associated PAH.
    Medication Details
    Drug Interactions

  • remodulin

    (treprostinil)
    United Therapeutics Corporation
    Remodulin is used to treat pulmonary arterial hypertension (PAH) to alleviate symptoms during exercise in patients with NYHA Functional Class II-IV. It is also indicated for those transitioning from epoprostenol to reduce clinical deterioration. Indications include idiopathic, heritable PAH, congenital shunts, and connective tissue diseases.
    Medication Details
    Drug Interactions

  • tyvaso dpi

    (treprostinil)
    United Therapeutics Corporation
    Tyvaso DPI is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability in patients, particularly those with NYHA Functional Class III symptoms. It is also indicated for pulmonary hypertension associated with interstitial lung disease (PH-ILD) to enhance exercise capacity.
    Medication Details
    Drug Interactions

  • unituxin

    (DINUTUXIMAB)
    United Therapeutics Corporation
    Unituxin (dinutuximab) is indicated for pediatric patients with high-risk neuroblastoma who show at least a partial response to prior multiagent therapy. It is used in combination with GM-CSF, IL-2, and 13-cis-retinoic acid for treatment.
    Medication Details
    Drug Interactions